梅花生物: management transactions · France · AMF SSE:600873 FR FR · AMF Mcap 28.4Bn€
Browse the full insider trade history of 梅花生物, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €28.4bn. The latest transaction was reported on 30 April 2026 — Purchase. Among the most active insiders: 常利斌. The full history is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 24.21 Bn€
Gross profit 4.60 Bn€ 19% margin
Net income 3.28 Bn€ 13.6% margin
Balance sheet & cash
Market cap 28.41 Bn€
Total debt 4.00 Bn€
Free Cash Flow 1.92 Bn€
Last declaration on 30 April 2026
Declarations 9 total
Executives ● Purchase11 SSE
348,000 shares
SSE:273000000582980500 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase22 SSE
12,268,200 shares
SSE:273000000494080580 · 23 Apr 2026
Ideal exit: 18 Jan 2027 (T+270) Executives ● Purchase7 SSE
1,534,600 shares
SSE:273000000501320060 · 23 Apr 2026
Ideal exit: 18 Jan 2027 (T+270) Executives ● Purchase7 SSE
3,811,800 shares
SSE:273000000501320000 · 23 Apr 2026
Ideal exit: 18 Jan 2027 (T+270) Executives ● Purchase14 SSE
177,200 shares
SSE:173000007665222500 · 20 May 2024
Ideal exit: 14 Feb 2025 (T+270) Executives ● Purchase7 SSE
355,700 shares
SSE:173000007665222460 · 20 May 2024
Ideal exit: 14 Feb 2025 (T+270) Executives ● Purchase7 SSE
190,000 shares
SSE:173000007482645150 · 10 Apr 2024
Ideal exit: 5 Jan 2025 (T+270) Executives ● Purchase7 SSE
210,000 shares
SSE:173000007482645200 · 9 Apr 2024
Ideal exit: 4 Jan 2025 (T+270) Executives ● Sale11 SSE
52,200 shares
SSE:173000005564067170 · 2 Jun 2022